Although lncRNA GAS5 has emerged as a promising target in the treatment of RA, the precise molecular mechanisms by which Tanshinone IIA regulates lncRNA GAS5 expression and downstream apoptotic pathways remain to be further studied. Here, GAS5 is linked to rheumatoid arthritis.